SCHEMBL27123769

SCHEMBL27123769

CCCCCC(CCCCC)C(CCCCCCCC(=O)O)(C(=O)O)C(CCCCC)CCCCC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.57
FFAR1 O14842 2/20 0.57
GPR84 Q9NQS5 7/20 0.55
PPARG P37231 7/20 0.55
PPARD Q03181 7/20 0.55
PPARA Q07869 7/20 0.55
HDAC11 Q96DB2 5/20 0.55
TSHR P16473 4/20 0.55
PTPN1 P18031 3/20 0.55
ALDH1A1 P00352 3/20 0.55
TLR2 O60603 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
FABP4 P15090 2/20 0.55
KMT2A Q03164 2/20 0.55
ALOX15 P16050 2/20 0.55
HSD17B10 Q99714 2/20 0.55
SLC22A6 Q4U2R8 1/20 0.55
SLC22A8 Q8TCC7 1/20 0.55
MEN1 O00255 1/20 0.55
ESR1 P03372 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14695990 0.95 FFAR1 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL14696587 0.95 FFAR1 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL7631438 0.95 FFAR1 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL6908018 0.95 FFAR1 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL591509 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL11316958 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL27998634 0.92 FFAR4 (0.53) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL28816546 0.92 FFAR4 (0.53) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL27998706 0.92 FFAR4 (0.53) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL3264787 0.88 AKR1B1 (0.47) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12629324-B2 Aqueous compositions comprising 6-undecanol-esters EVONIK OPERATIONS GMBH (DE) 2026-05-19 US disclosed
US-20240122831-A1 AQUEOUS COMPOSITIONS COMPRISING 6-UNDECANOL-ESTERS EVONIK OPERATIONS GMBH (DE) 2024-04-18 US disclosed
EP-4294785-A1 AQUEOUS COMPOSITIONS COMPRISING 6-UNDECANOL-ESTERS Evonik Operations GmbH (DE) 2023-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12629324-B2 Aqueous compositions comprising 6-undecanol-esters ELOVL6, SCD, ELOVL3 FFAR4 65/4885FFAR1 29/4885GPR84 2027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.